117 related articles for article (PubMed ID: 37163233)
1. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Desai PN; Wang B; Fonseca A; Borges P; Jelloul FZ; Reville PK; Lee E; Ly C; Basi A; Root J; Baran N; Post SM; Deng Q; Sun H; Harmanci AO; Burks JK; Gomez JA; DiNardo CD; Daver NG; Alatrash G; Konopleva M; Green MR; Antunes DA; Futreal A; Hao D; Abbas HA
Cancer Immunol Res; 2023 May; ():. PubMed ID: 37163233
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Desai PN; Wang B; Fonseca A; Borges P; Jelloul FZ; Reville PK; Lee E; Ly C; Basi A; Root J; Baran N; Post SM; Deng Q; Sun H; Harmanci AO; Burks JK; Gomez JA; DiNardo CD; Daver NG; Alatrash G; Konopleva M; Green MR; Antunes DA; Futreal A; Hao D; Abbas HA
Cancer Immunol Res; 2023 Jun; ():OF1-OF18. PubMed ID: 37285177
[TBL] [Abstract][Full Text] [Related]
3. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Root JL; Desai PN; Ly C; Wang B; Jelloul FZ; Zhou J; Mackay S; Alfayez M; Matthews J; Pierce S; Reville PK; Daver N; Abbas HA
Cancer Res Commun; 2024 Mar; 4(3):671-681. PubMed ID: 38391202
[TBL] [Abstract][Full Text] [Related]
6. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
7. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
8. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq reveals a microenvironment and an exhaustion state of T/NK cells in acute myeloid leukemia.
Zhang Z; Deng C; Zhu P; Yao D; Shi J; Zeng T; Huang W; Huang Z; Wu Z; Li J; Xiao M; Fu L
Cancer Sci; 2023 Oct; 114(10):3873-3883. PubMed ID: 37591615
[TBL] [Abstract][Full Text] [Related]
10. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Abbas HA; Hao D; Tomczak K; Barrodia P; Im JS; Reville PK; Alaniz Z; Wang W; Wang R; Wang F; Al-Atrash G; Takahashi K; Ning J; Ding M; Beird HC; Mathews JT; Little L; Zhang J; Basu S; Konopleva M; Marques-Piubelli ML; Solis LM; Parra ER; Lu W; Tamegnon A; Garcia-Manero G; Green MR; Sharma P; Allison JP; Kornblau SM; Rai K; Wang L; Daver N; Futreal A
Nat Commun; 2021 Oct; 12(1):6071. PubMed ID: 34663807
[TBL] [Abstract][Full Text] [Related]
11. Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse.
Odak I; Sikora R; Riemann L; Bayir LM; Beck M; Drenker M; Xiao Y; Schneider J; Dammann E; Stadler M; Eder M; Ganser A; Förster R; Koenecke C; Schultze-Florey CR
Front Immunol; 2022; 13():999163. PubMed ID: 36275657
[TBL] [Abstract][Full Text] [Related]
12. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
[TBL] [Abstract][Full Text] [Related]
13. Clonal expansion of bone marrow CD8
Feng Z; Fang Q; Kuang X; Liu X; Chen Y; Ma D; Wang J
Am J Cancer Res; 2020; 10(11):3973-3989. PubMed ID: 33294280
[TBL] [Abstract][Full Text] [Related]
14. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
[TBL] [Abstract][Full Text] [Related]
15. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling demonstrates altered characteristics of CD8
Abolhalaj M; Sincic V; Lilljebjörn H; Sandén C; Aab A; Hägerbrand K; Ellmark P; Borrebaeck CAK; Fioretos T; Lundberg K
Cancer Med; 2022 Aug; 11(15):3023-3032. PubMed ID: 35297213
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia.
Mazziotta F; Biavati L; Rimando JC; Rutella S; Borcherding N; Parbhoo S; Mukhopadhyay R; Knaus HA; Valent P; Hackl H; Borrello I; Blazar BR; Hatzi K; Gojo I; Luznik L
Blood; 2024 May; ():. PubMed ID: 38776511
[TBL] [Abstract][Full Text] [Related]
19. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with
Tan J; Chen S; Lu Y; Yao D; Xu L; Zhang Y; Yang L; Chen J; Lai J; Yu Z; Zhu K; Li Y
Chin J Cancer Res; 2017 Oct; 29(5):463-470. PubMed ID: 29142466
[TBL] [Abstract][Full Text] [Related]
20. BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8
Romine KA; MacPherson K; Cho HJ; Kosaka Y; Flynn PA; Byrd KH; Coy JL; Newman MT; Pandita R; Loo CP; Scott J; Adey AC; Lind EF
Leukemia; 2023 Mar; 37(3):580-592. PubMed ID: 36681742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
